Do I need a DHEA-Sulfate test?
Do you feel less energised than you used to, or notice changes in your mood and resilience? Your DHEA-Sulfate levels might offer an important clue. This hormone naturally declines with age, and understanding where yours sits can help you make informed choices about your wellbeing.
DHEA-Sulfate is an androgen precursor hormone your adrenal glands produce, playing a key role in synthesising sex hormones and supporting energy, mood, immune function, and metabolism.
Knowing your DHEA-Sulfate level can help you understand your body's hormonal patterns and how they may relate to your energy, emotional resilience, and overall vitality. This biomarker is part of Listen Health's comprehensive female health panel, giving you insight into the bigger picture of your hormonal health and empowering you to have informed conversations with your healthcare provider about what comes next.
What is it?
Dehydroepiandrosterone sulfate (DHEA-S) is an androgen precursor hormone produced primarily by the adrenal glands and, to a lesser extent, the ovaries. It plays a vital role in the synthesis of sex hormones (testosterone and estrogen), supports energy, mood, immune function, and helps regulate metabolism and sexual health. DHEA-S levels naturally peak in early adulthood and decline with age.
Book Your Test Now
Test DHEA-Sulfate as part of 100+ biomarkers with Listen Health's annual membership.
Start Testing TodayWhy does it matter?
The DHEA-S biomarker reflects adrenal androgen activity and provides insight into hormonal balance, stress adaptation, and metabolic function. Imbalances — either high or low — can have wide-ranging impacts on physical, emotional, and reproductive health.
High DHEA-S levels often signal adrenal overactivity or androgen excess, leading to symptoms of hormonal imbalance and conditions such as polycystic ovary syndrome (PCOS) or adrenal hyperplasia.
Low DHEA-S levels can reflect adrenal insufficiency, pituitary dysfunction, or age-related decline, and are linked to low libido, fatigue, and reduced bone and muscle mass.
Recommendations
If your DHEA-S is high:
Elevated DHEA-S levels increase circulating androgens and can result in:
Excess hair growth on the face or body (hirsutism)
Acne and oily skin
Hair thinning on the scalp
Menstrual irregularities or anovulation
Voice deepening or increased muscle mass
Common causes:
Polycystic Ovary Syndrome (PCOS)
Congenital Adrenal Hyperplasia (CAH)
Adrenal tumors or hyperplasia
Treatment focuses on addressing the underlying cause:
Lifestyle management (weight reduction, exercise, balanced nutrition) can help regulate insulin and reduce androgen levels in PCOS.
Oral contraceptives can suppress excess androgen production.
Anti-androgen medications such as spironolactone may reduce acne and hair growth.
Regular endocrine monitoring helps track treatment response and hormone normalization
If your DHEA-S is low:
Low DHEA-S levels are more common with aging, chronic stress, or adrenal insufficiency, and may present as:
Low libido and sexual dissatisfaction
Fatigue and low energy
Depressive symptoms or apathy
Reduced muscle tone or bone density
Poor stress tolerance
Common causes:
Primary Adrenal Insufficiency (Addison’s disease)
Hypopituitarism or HPA axis suppression
Chronic illness, stress, or aging
Treatment Approach:
Address underlying causes — treat adrenal or pituitary disorders where present.
DHEA supplementation: The Endocrine Society recommends a 6-month trial of DHEA replacement in women with adrenal insufficiency and persistent low libido, energy, or mood symptoms despite other hormone therapy. Morning DHEA-S levels should be monitored and maintained in the mid-normal range.
Hormonal support: In some cases, testosterone or combined androgen therapy may help improve bone density, muscle mass, mood, and sexual well-being.
Lifestyle interventions — regular movement, adequate sleep, and a nutrient-dense diet (rich in B vitamins, zinc, and healthy fats) support adrenal health and hormone synthesis.
References
Elhassan, Y. S., Hawley, J. M., Cussen, L., et al. (2025). Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women. Clinical Endocrinology, 103(4), 540–566. https://doi.org/10.1111/cen.15265
Wierman, M. E., Arlt, W., Basson, R., et al. (2014). Androgen therapy in women: A reappraisal: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 99(10), 3489–3510. https://doi.org/10.1210/jc.2014-2260
Bornstein, S. R., Allolio, B., Arlt, W., et al. (2016). Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 101(2), 364–389. https://doi.org/10.1210/jc.2015-1710
Wierman, M. E., & Kiseljak-Vassiliades, K. (2022). Should dehydroepiandrosterone be administered to women? The Journal of Clinical Endocrinology & Metabolism, 107(6), 1679–1685. https://doi.org/10.1210/clinem/dgac130
Frequently Asked Questions
Related Biomarkers
Testosterone, Free
Free Androgen Index (FAI)
Sex Hormone Binding Globulin
Haematocrit
Triiodothyronine (T3) Free
Transferrin Saturation
AHPRA Disclaimer: This information is general in nature and should not replace individual medical advice. Always discuss your test results and health concerns with a registered healthcare practitioner.